PsyBio Therapeutics Corp. PSYB.V Stock
PsyBio Therapeutics Corp. Price Chart
PsyBio Therapeutics Corp. PSYB.V Financial and Trading Overview
| PsyBio Therapeutics Corp. stock price | 0.0100 CAD |
| Previous Close | 0.03 CAD |
| Open | 0.03 CAD |
| Bid | 0.02 CAD x N/A |
| Ask | 0.03 CAD x N/A |
| Day's Range | 0.03 - 0.03 CAD |
| 52 Week Range | 0.02 - 0.2 CAD |
| Volume | 10K CAD |
| Avg. Volume | 92.29K CAD |
| Market Cap | 3.32M CAD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2 CAD |
PSYB.V Valuation Measures
| Enterprise Value | 3.32M CAD |
| Trailing P/E | N/A |
| Forward P/E | -0.3125 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
PsyBio Therapeutics Corp. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -73.68% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.2 CAD |
| 52 Week Low | 0.02 CAD |
| 50-Day Moving Average | 0.03 CAD |
| 200-Day Moving Average | 0.07 CAD |
PSYB.V Share Statistics
| Avg. Volume (3 month) | 92.29K CAD |
| Avg. Daily Volume (10-Days) | 89.79K CAD |
| Shares Outstanding | 83.93M |
| Float | N/A |
| Short Ratio | 0.04 |
| % Held by Insiders | 19.84% |
| % Held by Institutions | 10.25% |
| Shares Short | 6.01K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | -0.014 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of PsyBio Therapeutics Corp.
| Country | Canada |
| State | CO |
| City | Denver |
| Address | 1624 Washington Street |
| ZIP | 80203 |
| Phone | 513 449 9585 |
| Website | https://www.psybiolife.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
PsyBio Therapeutics Corp., a biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. PsyBio Therapeutics Corp. was formerly known as Leo Acquisitions Corp. and changed its name to PsyBio Therapeutics Corp. in January 2021. The company is headquartered in Denver, Colorado.
Q&A For PsyBio Therapeutics Corp. Stock
What is a current PSYB.V stock price?
PsyBio Therapeutics Corp. PSYB.V stock price today per share is 0.0100 CAD.
How to purchase PsyBio Therapeutics Corp. stock?
You can buy PSYB.V shares on the TSXV exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PsyBio Therapeutics Corp.?
The stock symbol or ticker of PsyBio Therapeutics Corp. is PSYB.V.
Which industry does the PsyBio Therapeutics Corp. company belong to?
The PsyBio Therapeutics Corp. industry is Biotechnology.
How many shares does PsyBio Therapeutics Corp. have in circulation?
The max supply of PsyBio Therapeutics Corp. shares is 127.54M.
What is PsyBio Therapeutics Corp. Price to Earnings Ratio (PE Ratio)?
PsyBio Therapeutics Corp. PE Ratio is 0.00000000 now.
What was PsyBio Therapeutics Corp. earnings per share over the trailing 12 months (TTM)?
PsyBio Therapeutics Corp. EPS is 0 CAD over the trailing 12 months.
Which sector does the PsyBio Therapeutics Corp. company belong to?
The PsyBio Therapeutics Corp. sector is Healthcare.